Variables | Days | Groups | Significance level (Independent T-test/ Mann-Whitney) | Significance level ( GEE*time ) | |
---|---|---|---|---|---|
Atorvastatin | Placebo | ||||
Halo diameter (mm) | 0 | 1.32 ± 4.31 | 1.40 ± 4.40 | 0.826 | 0.072 |
3 | 1.36 ± 3.18 | 1.26 ± 4.45 | *0.003 | ||
5 | 1.18 ± 1.50 | 1.40 ± 2.8 | ∗0.003 | ||
7 | 0.59 ± 0.45 | 1.16 ± 1.27 | ∗0.014 | ||
Significance level (Friedman) | 0.000∗ | 0.000∗ | |||
Pain intensity | 1 | 1.37 ± 7.48 | 1.26 ± 7.45 | 0.936 | 0.162 |
2 | 1.05 ± 6.31 | 1.51 ± 7.10 | 0.052 | ||
3 | 1.37 ± 4.84 | 1.57 ± 6.27 | *0.003 | ||
4 | 1.33 ± 3.34 | 1.88 ± 5.28 | *0.000 | ||
5 | 1.36 ± 2.63 | 1.85 ± 4.37 | *0.001 | ||
6 | 1.01 ± 1.56 | 1.63 ± 2.78 | *0.005 | ||
7 | 0.80 ± 0.98 | 1.30 ± 1.28 | 0.821 | ||
Significance level (Friedman) | *0.000 | *0.000 |